<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融投资 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-14T16:55:51+08:00</updated>
  <subtitle>医药行业</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>Biotech Top：信达生物市值1340亿；全球研发中心落上海</title>
    <updated>2021-01-14T16:32:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/AXcgLtHS_IHDdI6JGg01tg</id>
    <link href="https://mp.weixin.qq.com/s/AXcgLtHS_IHDdI6JGg01tg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首个CAR-T疗法！复星凯特「益基利仑赛注射液」即将获批上市</title>
    <updated>2021-01-14T16:32:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/3zwwQr-f7miG_MjaQHXBng</id>
    <link href="https://mp.weixin.qq.com/s/3zwwQr-f7miG_MjaQHXBng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>益方生物科创板辅导中：KRAS美国已临床启动</title>
    <updated>2021-01-11T13:35:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/hw2F4tya4LbCJCr4zriyFA</id>
    <link href="https://mp.weixin.qq.com/s/hw2F4tya4LbCJCr4zriyFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>琅琊榜—2020年CXO公司国际化程度排排坐</title>
    <updated>2021-01-11T13:35:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/YASET-PJm2wdKJWMQL6Q7Q</id>
    <link href="https://mp.weixin.qq.com/s/YASET-PJm2wdKJWMQL6Q7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>自身免疫新兵：创响生物与和黄达成2.3亿美元合作</title>
    <updated>2021-01-11T13:28:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/IdhXSgSC5Mkq6-yMsddLvw</id>
    <link href="https://mp.weixin.qq.com/s/IdhXSgSC5Mkq6-yMsddLvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融圈发布：男女均有效！开拓药业普克鲁胺阻止新冠患者轻症向重症转化，效果显著</title>
    <updated>2021-01-11T13:28:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/lLP38ji99XA95HRV4PQS7A</id>
    <link href="https://mp.weixin.qq.com/s/lLP38ji99XA95HRV4PQS7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【产业观察】以为小适应症，结果TRK新药大热门</title>
    <updated>2021-01-11T13:28:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/4JRG1Oz5OEvG16O2ZfK2Ww</id>
    <link href="https://mp.weixin.qq.com/s/4JRG1Oz5OEvG16O2ZfK2Ww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融圈发布：小分子新锐再极医药完成近2亿融资</title>
    <updated>2021-01-06T09:21:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/yzlOJbDWtA5FfMUPtdzAOg</id>
    <link href="https://mp.weixin.qq.com/s/yzlOJbDWtA5FfMUPtdzAOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>零度下的思考，差异化的机遇—未来10年医药业7大变局</title>
    <updated>2021-01-06T09:21:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/u8skAyvhT5klPjFbJnKPKQ</id>
    <link href="https://mp.weixin.qq.com/s/u8skAyvhT5klPjFbJnKPKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>布局代谢及免疫：诚益生物完成新一轮超亿元融资</title>
    <updated>2020-12-22T09:20:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/RkRnXoOJ27Ge-O6Q0-ilaQ</id>
    <link href="https://mp.weixin.qq.com/s/RkRnXoOJ27Ge-O6Q0-ilaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺华siRNA新药获批：革命性降脂药物，一年仅2针的PCSK9</title>
    <updated>2020-12-22T09:20:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/bh-uC8cITM72_n8313-C6Q</id>
    <link href="https://mp.weixin.qq.com/s/bh-uC8cITM72_n8313-C6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>宇宙大药厂：辉瑞Pipeline解析，目前92项火热在研</title>
    <updated>2020-12-21T11:05:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/cmaQxZJG4l8hv97s96ml1g</id>
    <link href="https://mp.weixin.qq.com/s/cmaQxZJG4l8hv97s96ml1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科创板之风下：盟科药业完成7亿融资</title>
    <updated>2020-12-21T11:05:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/yM20N1A23jRRxQK-gajA3A</id>
    <link href="https://mp.weixin.qq.com/s/yM20N1A23jRRxQK-gajA3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>门冬胰岛素30注射液首家国产：中国胰岛素之王的全球创新之路</title>
    <updated>2020-12-15T13:38:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/Rsrgtdle00ui9z-bDx72Pg</id>
    <link href="https://mp.weixin.qq.com/s/Rsrgtdle00ui9z-bDx72Pg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最贵原料药之一：药化界珠穆朗玛峰，艾立布林</title>
    <updated>2020-12-15T13:38:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/kUR2EC-WYSjvn3rr-0KGDg</id>
    <link href="https://mp.weixin.qq.com/s/kUR2EC-WYSjvn3rr-0KGDg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药石新药布局：转让项目价格来了</title>
    <updated>2020-12-14T10:22:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/ojWzLF5CuG8BeZsqqrkyTA</id>
    <link href="https://mp.weixin.qq.com/s/ojWzLF5CuG8BeZsqqrkyTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞再磨一剑：国产PARP新药即将首家获批</title>
    <updated>2020-12-14T10:22:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/u9Cp-6l0su5eygxOXdqUfQ</id>
    <link href="https://mp.weixin.qq.com/s/u9Cp-6l0su5eygxOXdqUfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和铂医药成功香港上市；FcRn全球领先</title>
    <updated>2020-12-11T12:13:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/xWjPtGycsRKCMDOeXBBIKA</id>
    <link href="https://mp.weixin.qq.com/s/xWjPtGycsRKCMDOeXBBIKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>眼科赛道持续升温，兆科眼科即将上市；数十家企业布局</title>
    <updated>2020-12-11T12:13:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/cnfnS7F58eWI8hoFAzC88Q</id>
    <link href="https://mp.weixin.qq.com/s/cnfnS7F58eWI8hoFAzC88Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>利民博士再起航：专注CNS新药，获顶级机构1亿美元投资</title>
    <updated>2020-12-09T10:00:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/0IFNBmPOUGbeBHkXyrnuRw</id>
    <link href="https://mp.weixin.qq.com/s/0IFNBmPOUGbeBHkXyrnuRw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>